The Novel Melatonin Analog Containing Donepezil Fragment Prevents Cognitive Impairments and Associated Oxidative Stress in a Hybrid Rat Model of Melatonin Deficiency and icvAβ1-42
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26146553 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Petya Ivanova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Melatonin, Donepezil, Oxidative Stress, Amyloid beta-Peptides. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Bulgarian National Science Fund, Bulgarian Academy of Sciences, Bulgarian National Science Fund.
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the most common cause of dementia in older adults and is becoming a major public health crisis as life expectancy increases worldwide. A major contributor to this disease is a deficiency in melatonin signaling. We have recently synthesised a series of melatonin analogs containing donepezil fragments. These compounds have been tested both in silico and in vitro. In this study, a particularly potent compound, 3a, was evaluated in a hybrid rat model of melatonin deficiency and AD. Rats underwent pinealectomy followed one week later by bilateral intracerebroventricular infusion of Aβ1-42 (1 µg/µL). A 14-day subchronic treatment with compound 3a was started simultaneously with the neurotoxin infusion. Melatonin was used as a reference drug, while a matched sham group received vehicle treatment. One week after the Aβ1-42 infusion, the rats’ cognitive functions were assessed using two Y-maze protocols, object recognition and object location tests. Markers of oxidative stress, including hippocampal glutathione, superoxide dismutase, and malondialdehyde, were assessed by ELISA. Compound 3a effectively prevented cognitive impairment induced by the AD model, and its effects were comparable to those of melatonin. In addition, this melatonin analogue with a donepezil fragment reduced AD-associated oxidative stress and suppressed model-associated increased Aβ1-42 levels in the hippocampus. Our findings suggest that melatonin analogs containing donepezil fragments are promising therapeutic options for targeting oxidative stress associated with AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
- Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
ORCID-Profile: Violina T Angelova, Jana Tchekalarova
Förderung
- the Bulgarian National Science Fund, Bulgarian Academy of Sciences
- Bulgarian National Science Fund
Zitieren
APA
Ivanova, P., Kortenska, L., Angelova, V. T., & Tchekalarova, J. (2025). The Novel Melatonin Analog Containing Donepezil Fragment Prevents Cognitive Impairments and Associated Oxidative Stress in a Hybrid Rat Model of Melatonin Deficiency and icvAβ1-42. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146553
Vancouver
Ivanova P, Kortenska L, Angelova VT, Tchekalarova J. The Novel Melatonin Analog Containing Donepezil Fragment Prevents Cognitive Impairments and Associated Oxidative Stress in a Hybrid Rat Model of Melatonin Deficiency and icvAβ1-42. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146553
BibTeX
@article{Ivanova2025,
author = {Ivanova, Petya and Kortenska, Lidia and Angelova, Violina T and Tchekalarova, Jana},
title = {The Novel Melatonin Analog Containing Donepezil Fragment Prevents Cognitive Impairments and Associated Oxidative Stress in a Hybrid Rat Model of Melatonin Deficiency and icvAβ1-42},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26146553}
}
EUVIMED